Publication in refereed journal
香港中文大学研究人员 ( 现职)
| 汤宁信教授 |
| 李咏恩教授 (药剂学院) |
| 汤宁信教授 |
| 李?前教授 (药剂学院) |
全文
| 数位物件识别号 (DOI) http://dx.doi.org/10.1177/1074248410380207 |
引用次数
Web of Sciencehttp://aims.cuhk.edu.hk/converis/portal/Publication/5WOS source URL
其它资讯
摘要Objective: To assess the clinical and economic outcomes of a clinical pharmacy service (CPS) in dyslipidemic management. Method: This was a 24-month prospective controlled trial conducted at the lipid clinic of a public hospital in Hong Kong. In the intervention group, a clinical pharmacist assessed low-density lipoprotein cholesterol (LDL-C) levels and provided recommendations in accordance to the Adult Treatment Panel III (ATP III) guidelines. Medication compliance and the proper use of drugs were assessed. Education on healthy lifestyles was reinforced. Monthly telephone follow-ups were made to check on the progress of patients. In the control group, patients received usual medical care with no pharmacist intervention. Primary outcome was the percentage of patients achieving the ATP III LDL-C goal at the end of study. The estimated cost of such service was also evaluated. Results: A total of 300 patients were recruited into the study (1http://aims.cuhk.edu.hk/converis/portal/Publication/50 in intervention group and 1http://aims.cuhk.edu.hk/converis/portal/Publication/50 in control group). In the intervention group, http://aims.cuhk.edu.hk/converis/portal/Publication/58.7% patients achieved LDL-C goals compared with 4http://aims.cuhk.edu.hk/converis/portal/Publication/5.3% in the control group (P < .0http://aims.cuhk.edu.hk/converis/portal/Publication/5). The intervention group achieved 26.4%, 17.4%, and 30.0% mean reduction in LDL-C, total cholesterol (TC), and triglycerides (TG) levels, respectively, compared with 12.6%, 6.6%, and 11.http://aims.cuhk.edu.hk/converis/portal/Publication/5% in the control group (P < .0http://aims.cuhk.edu.hk/converis/portal/Publication/5). The estimated cost for this clinical service was US$38http://aims.cuhk.edu.hk/converis/portal/Publication/5/month for a total of 600 dyslipidemic patients seen per year. Conclusion: The results of this study demonstrate the positive impact CPS can have on achieving treatment goals in lipid management. Similar services for other problematic conditions such as hypertension and diabetes mellitus may also be benefited by similar CPSs.
着者Chung JST, Lee KKC, Tomlinson B, Lee VWY
期刊名称JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
详细描述online publication: doi: 10.1177/1074248410380207
出版年份2011
月份3
日期1
卷号16
期次1
出版社SAGE Publications (UK and US)
页次43 - http://aims.cuhk.edu.hk/converis/portal/Publication/52
国际标準期刊号1074-2484
语言英式英语
关键词clinical pharmacy service; coronary heart disease; dyslipidemia
Web of Science 学科类别Cardiac & Cardiovascular Systems; CARDIAC & CARDIOVASCULAR SYSTEMS; Cardiovascular System & Cardiology; Pharmacology & Pharmacy; PHARMACOLOGY & PHARMACY
